NRC
National Research Corp.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$25.16
+4.53%Year over year
Reported trailing growth
- Revenue
- +3.4%
- EBITDA
- -29.1%
- EBIT
- -42.2%
- EPS
- -57.1%
- Free cash flow
- +58.7%
- Operating cash flow
- -7.3%
Forward estimates
Based on analyst estimates
- Revenue
- +6.8%
- EBITDA
- +77.6%
- EPS
- +227.3%
Three-year CAGR
- Revenue
- -3.2%
- EBITDA
- -15.0%
- EBIT
- -21.4%
- Net income
- -28.5%
- EPS
- -25.9%
- Free cash flow
- -15.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026